SeaStar Medical Holding Corp

SeaStar Medical Holding Corp, which files under the ticker LMAO on the Nasdaq Capital Market, submitted an amended current report on Form 8-K/A to the SEC on August 14, 2025. The company traces its origins to LMF Acquisition Opportunities Inc., a blank-check vehicle that completed its IPO in 2021 and was sponsored by LMFA SPAC Holdings LLC, an affiliate of LM Funding America Inc. SeaStar Medical operates in the medical device sector, with its core technology targeting acute kidney injury and inflammatory conditions in critically ill patients. The de-SPAC merger closed in 2022, with the combined entity retaining the LMAO ticker. For complete SPAC profiles, sponsor data, and filing analytics, sign up for full access on SpacDesk.